Transenterix Inc. (TRXC)

Trade TRXC now with
2/12/2020 6:53:00 AM TransEnterix Announces CE Mark Approval For Pediatric Indication For Senhance Surgical System
1/21/2020 7:00:58 AM TransEnterix Announces Klinikum Esslingen To Initiate A Senhance Surgical System Program
1/14/2020 6:57:03 AM TransEnterix Announces Submission Of 510(k) To FDA For First Machine Vision System In Robotic Surgery
1/8/2020 7:10:55 AM TransEnterix Says Ochsner Health System Enters Agreement To Lease And Utilize Senhance(r) System
1/2/2020 4:13:32 PM TransEnterix Appoints Brett Farabaugh As Interim CFO
10/30/2019 6:22:58 AM TransEnterix Announces Plan For Reverse Stock Split
8/1/2019 8:00:43 AM TransEnterix Announces Broad Reimbursement Approval In Japan For Senhance Digital Laparoscopy System
7/10/2019 1:30:16 PM TransEnterix Announces Sale Of AutoLap Assets To Great Belief Int'l
5/28/2019 7:00:59 AM TransEnterix Receives Japanese Regulatory Approval For Senhance Surgical System
1/15/2019 6:56:30 AM TransEnterix Receives FDA 510(k) Clearance For Senhance Ultrasonic System
1/7/2019 6:57:45 AM TransEnterix Expects Q4 Revenue Of About $7.4 Mln
10/11/2018 6:56:42 AM TransEnterix Receives FDA 510(k) Clearance For 3mm Diameter Instruments
10/1/2018 6:56:40 AM TransEnterix Receives CE Mark Approval For Senhance Ultrasonic Instrument System
9/6/2018 6:55:45 AM TransEnterix Files FDA 510(k) Submission For Senhance Ultrasonic Instrument System
9/4/2018 4:08:16 PM TransEnterix Appoints Eric Smith As Chief Commercial Officer
8/7/2018 6:59:41 AM TransEnterix Q2 Net Loss $34.2 Mln Or $0.17/Shr Vs Loss Of $14.7 Mln Or $0.11/shr Last Year